IL1A and neoplasm: Immunoenhancing molecular mechanisms of COS could precede either with direct killing of pathogenic microorganisms or tumor cells because of an immune response or with enhancement of cytotoxic activity to inhibit the production of tumor cells by activation of T-cells and NK-cells with the help of IL-1 and TNF-α cytokines [87, 88].